-
Check the chart of your next patient. She says she has vaginal itching and irritation, odor, and vaginal discharge. What is your next step?
-
The Food and Drug Administration (FDA) has ruled out mifepristone (Mifeprex, Danco Laboratories, New York City) as the cause in one of two recent deaths of women who had taken the drug. The agency is continuing to investigate the other death.
-
When it comes to sexually transmitted diseases (STDs), new data released by the American Social Health Association (ASHA) in Research Triangle Park, NC, shows that the average age of people who are tested for chlamydia is 28.9 for women and 30.5 for men.
-
Early research in rhesus monkeys indicates that a combination of two AIDS treatment drugs, tenofovir (TDF, Viread, Gilead; Foster City, CA) and emtricitabine (FTC, Emtriva; Gilead), may be effective in HIV prevention.
-
Call it "crystal," "tina," or "crank," use of crystal methamphetamine is cutting across all socioeconomic and sexual boundaries. How does that affect your family planning facility?
-
A group from Australia recently published a study that provides some insight about miscarriage after 8 weeks of gestation. They analyzed data from 1050 patients having in vitro fertilization. Serum hCG levels were measured at 16 days post-conception (approximately for menstrual weeks).
-
A retrospective chart review in 219 of 731 randomly selected cases of appendicitis was conducted at 2 municipal/tertiary care hospitals.
-
The updated breast cancer results in the canceled estrogen-only arm of the Womens Health Initiative (WHI) are based on 237 cases of invasive breast cancer and 55 cases of cancer in situ, diagnosed by the February 29, 2004, date of study cancellation.
-
-
It has been recently identified that NADIR values in serial CA125 values during adjuvant primary post-operative chemotherapy are prognostic even within the normal range (less than 35).